Profile | GDS4284 / 217827_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 3304.95 | 89 |
GSM687648 | Patient 402 control | 4683.34 | 93 |
GSM687653 | Patient 403 control | 4062.01 | 91 |
GSM687658 | Patient 404 control | 3549.87 | 90 |
GSM687663 | Patient 411 control | 3371.93 | 90 |
GSM687668 | Patient 422 control | 3936.51 | 91 |
GSM687673 | Patient 424 control | 3043.74 | 89 |
GSM687678 | Patient 425 control | 3621.32 | 91 |
GSM687683 | Patient 427 control | 3276.04 | 90 |
GSM687688 | Patient 428 control | 4556.78 | 93 |
GSM687695 | Patient 441 control | 5324.67 | 94 |
GSM687699 | Patient 443 control | 2480.2 | 87 |
GSM687704 | Patient 444 control | 2685.64 | 87 |
GSM687707 | Patient 448 control | 3293.28 | 90 |
GSM687712 | Patient 449 control | 3572.35 | 90 |
GSM687719 | Patient 450 control | 2737.62 | 88 |
GSM687724 | Patient 451 control | 2754.01 | 88 |
GSM687728 | Patient 452 control | 4147.77 | 92 |
GSM687646 | Patient 401 treated 24h | 3232.5 | 89 |
GSM687649 | Patient 402 treated 24h | 4054.53 | 91 |
GSM687665 | Patient 411 treated 24h | 3077.17 | 89 |
GSM687651 | Patient 402 treated 4 weeks | 4421.92 | 92 |
GSM687667 | Patient 411 treated 4 weeks | 3946.49 | 91 |
GSM687670 | Patient 422 treated 24h | 3708.08 | 91 |
GSM687671 | Patient 422 treated 4 weeks | 4490.94 | 92 |
GSM687654 | Patient 403 treated 24h | 4058.24 | 91 |
GSM687675 | Patient 424 treated 24h | 3869.48 | 91 |
GSM687685 | Patient 427 treated 24h | 3589.21 | 90 |
GSM687656 | Patient 403 treated 4 weeks | 4188.81 | 92 |
GSM687677 | Patient 424 treated 4 weeks | 3294.93 | 90 |
GSM687687 | Patient 427 treated 4 weeks | 3180.99 | 89 |
GSM687692 | Patient 428 treated 4h | 4077.17 | 92 |
GSM687716 | Patient 449 treated 4h | 3170.9 | 89 |
GSM687722 | Patient 450 treated 4h | 2364.36 | 86 |
GSM687680 | Patient 425 treated 24h | 3615.89 | 90 |
GSM687690 | Patient 428 treated 24h | 5129.2 | 93 |
GSM687700 | Patient 443 treated 24h | 2922.36 | 89 |
GSM687705 | Patient 444 treated 24h | 3213.64 | 89 |
GSM687714 | Patient 449 treated 24h | 3814.31 | 91 |
GSM687721 | Patient 450 treated 24h | 2591.73 | 87 |
GSM687682 | Patient 425 treated 4 weeks | 3697.51 | 91 |
GSM687694 | Patient 428 treated 4 weeks | 4242.9 | 92 |
GSM687702 | Patient 443 treated 4 weeks | 3611.21 | 91 |
GSM687718 | Patient 449 treated 4 weeks | 3312.33 | 90 |
GSM687723 | Patient 450 treated 4 weeks | 2917.79 | 88 |
GSM687661 | Patient 404 treated 4h | 3054.29 | 89 |
GSM687710 | Patient 448 treated 4h | 4889.53 | 93 |
GSM687726 | Patient 451 treated 4h | 3241.58 | 90 |
GSM687730 | Patient 452 treated 4h | 3176.19 | 91 |
GSM687660 | Patient 404 treated 24h | 4076.69 | 92 |
GSM687697 | Patient 441 treated 24h | 4752.73 | 93 |
GSM687709 | Patient 448 treated 24h | 3870.24 | 91 |
GSM687725 | Patient 451 treated 24h | 2383.4 | 86 |
GSM687729 | Patient 452 treated 24h | 7067.02 | 95 |
GSM687727 | Patient 451 treated 4 weeks | 3451.32 | 90 |
GSM687731 | Patient 452 treated 4 weeks | 4541.82 | 93 |